Cardiff Oncology, Inc. (CRDF) quarterly income statement — complete revenue, gross profit & net income history
Cardiff Oncology, Inc. (CRDF) annual income statement — 18-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 104K | 41K | 243K | 120K | 121K | 109K | 151K | 165K | 163K | 205K | 156K | 141K | 108K | 83K | 128K | 93K | 91K | 74K | 133K | 86K |
| Revenue Growth % | -14.05% | -62.39% | 60.93% | -27.27% | -25.77% | -46.83% | -3.21% | 17.02% | 50.93% | 146.99% | 21.88% | 51.61% | 18.68% | 12.16% | -3.76% | 8.14% | 33.82% | 2.78% | 11.53% | -36.76% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 11.58M | 0 | 0 | 9.64M | 105K | 102K | 103K | 107K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | 9570.25% | - | - | 5842.42% | 64.42% | 49.76% | 66.03% | 75.89% | - | - | - | - | - | - | - | - |
| Gross Profit | 104K | 41K | 243K | 120K | -11.46M | 109K | 151K | -9.47M | 58K | 103K | 53K | 34K | 108K | 83K | 128K | 93K | 91K | 74K | 133K | 86K |
| Gross Margin % | 100% | 100% | 100% | 100% | -9470.25% | 100% | 100% | -5742.42% | 35.58% | 50.24% | 33.97% | 24.11% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | 100.91% | -62.39% | 60.93% | 101.27% | -19856.9% | 5.83% | 184.91% | -27967.65% | -46.3% | 24.1% | -58.59% | -63.44% | 18.68% | 12.16% | -3.76% | 8.14% | 33.82% | 2.78% | 11.53% | -36.76% |
| Operating Expenses | 9.72M | 12.89M | 8.07M | 12.09M | 3.32M | 14.49M | 12.72M | 3.13M | 12.6M | 11.04M | 10.38M | 10.85M | 12.32M | 12.13M | 9.52M | 9.09M | 10.53M | 11.15M | 9.66M | 7.08M |
| OpEx % of Revenue | 9345.19% | 31441.46% | 3320.99% | 10078.33% | 2742.15% | 13294.5% | 8425.83% | 1894.55% | 7731.9% | 5383.41% | 6657.05% | 7697.87% | 11403.7% | 14620.48% | 7437.5% | 9769.89% | 11575.82% | 15064.86% | 7262.41% | 8237.21% |
| Selling, General & Admin | 3.8M | 6.13M | 3M | 3.9M | 0 | 4.01M | 3.01M | 0 | 3.21M | 3.03M | 2.73M | 2.94M | 4.3M | 3.08M | 3.08M | 3.08M | 3.09M | 3.94M | 3.83M | 2.93M |
| SG&A % of Revenue | 3657.69% | 14941.46% | 1232.51% | 3247.5% | - | 3682.57% | 1994.04% | - | 1972.39% | 1477.07% | 1746.79% | 2084.4% | 3977.78% | 3714.46% | 2404.69% | 3308.6% | 3391.21% | 5324.32% | 2883.46% | 3406.98% |
| Research & Development | 5.92M | 6.76M | 5.08M | 8.2M | 11.58M | 10.48M | 9.71M | 9.64M | 9.49M | 8.01M | 7.76M | 8.02M | 8.02M | 9.05M | 6.44M | 6.01M | 7.45M | 7.21M | 5.82M | 4.15M |
| R&D % of Revenue | 5687.5% | 16500% | 2088.48% | 6830.83% | 9570.25% | 9611.93% | 6431.79% | 5842.42% | 5823.93% | 3906.34% | 4976.28% | 5689.36% | 7425.93% | 10906.02% | 5032.81% | 6461.29% | 8184.62% | 9740.54% | 4378.95% | 4830.23% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | -1000K | 0 | 0 | -1000K | -105K | 0 | -103K | -107K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.62M | -12.85M | -7.83M | -11.97M | -14.78M | -14.38M | -12.57M | -12.6M | -12.54M | -10.93M | -10.33M | -10.82M | -12.21M | -12.05M | -9.39M | -8.99M | -10.44M | -11.07M | -9.53M | -7M |
| Operating Margin % | -9245.19% | -31341.46% | -3220.99% | -9978.33% | -12212.4% | -13194.5% | -8325.83% | -7636.97% | -7696.32% | -5333.17% | -6623.08% | -7673.76% | -11303.7% | -14520.48% | -7337.5% | -9669.89% | -11475.82% | -14964.86% | -7162.41% | -8137.21% |
| Operating Income Growth % | 34.93% | 10.65% | 37.74% | 4.98% | -17.79% | -31.55% | -21.68% | -16.46% | -2.76% | 9.28% | -10.01% | -20.32% | -16.9% | -8.83% | 1.41% | -28.51% | -51.59% | -103.49% | -46.62% | -60.39% |
| EBITDA | -9.44M | -12.63M | -7.6M | -11.48M | -14.68M | -14.15M | -12.48M | -12.5M | -12.44M | -10.83M | -10.23M | -10.71M | -12.11M | -11.96M | -9.31M | -8.91M | -10.4M | -11.04M | -9.41M | -6.89M |
| EBITDA Margin % | -9077.88% | -30802.44% | -3129.22% | -9566.67% | -12134.71% | -12985.32% | -8262.25% | -7575.76% | -7631.9% | -5283.41% | -6557.05% | -7597.87% | -11212.96% | -14412.05% | -7270.31% | -9582.8% | -11434.07% | -14922.97% | -7077.44% | -8009.3% |
| EBITDA Growth % | 35.7% | 10.77% | 39.05% | 8.16% | -18.03% | -30.68% | -21.97% | -16.68% | -2.73% | 9.45% | -9.92% | -20.21% | -16.39% | -8.32% | 1.14% | -29.38% | -53.47% | -107.46% | -47.55% | -62.15% |
| D&A (Non-Cash Add-back) | 174K | 221K | 223K | 494K | 94K | 228K | 96K | 101K | 105K | 102K | 103K | 107K | 98K | 90K | 86K | 81K | 38K | 31K | 113K | 110K |
| EBIT | -9.23M | -12.35M | -7.22M | -11.26M | -13.94M | -13.43M | -11.79M | -11.86M | -11.78M | -10.01M | -9.34M | -10.82M | -12.21M | -12.05M | -9.39M | -8.99M | -10.44M | -11.07M | -8.96M | -7M |
| Net Interest Income | 382K | 506K | 612K | 716K | 835K | 941K | 787K | 741K | 805K | 926K | 1.01M | 1.07M | 1.05M | 940K | 740K | 458K | 253K | 130K | 79K | 70K |
| Interest Income | 382K | 506K | 612K | 716K | 835K | 941K | 787K | 741K | 805K | 926K | 1.01M | 1.07M | 1.05M | 940K | 740K | 458K | 253K | 130K | 79K | 70K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 383K | 505K | 611K | 716K | 834K | 948K | 785K | 746K | 767K | 922K | 995K | 1.09M | 1.06M | 829K | 695K | 422K | 0 | 81K | 84K | 85K |
| Pretax Income | -9.23M | -12.35M | -7.22M | -11.26M | -13.94M | -13.43M | -11.79M | -11.86M | -11.78M | -10.01M | -9.34M | -9.73M | -11.15M | -11.22M | -8.7M | -8.57M | -10.44M | -10.99M | -9.44M | -6.91M |
| Pretax Margin % | -8876.92% | -30109.76% | -2969.55% | -9381.67% | -11523.14% | -12324.77% | -7805.96% | -7184.85% | -7225.77% | -4883.41% | -5985.26% | -6901.42% | -10324.07% | -13521.69% | -6794.53% | -9216.13% | -11475.82% | -14855.41% | -7099.25% | -8038.37% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -9.23M | -12.35M | -7.22M | -11.26M | -13.94M | -13.43M | -11.79M | -11.86M | -11.78M | -10.01M | -9.34M | -9.73M | -11.15M | -11.22M | -8.7M | -8.57M | -10.44M | -10.99M | -9.44M | -6.91M |
| Net Margin % | -8876.92% | -30109.76% | -2969.55% | -9381.67% | -11523.14% | -12324.77% | -7805.96% | -7184.85% | -7225.77% | -4883.41% | -5985.26% | -6901.42% | -10324.07% | -13521.69% | -6794.53% | -9216.13% | -11475.82% | -14855.41% | -7099.25% | -8038.37% |
| Net Income Growth % | 33.79% | 8.11% | 38.78% | 5.04% | -18.38% | -34.19% | -26.24% | -21.83% | -5.63% | 10.8% | -7.36% | -13.53% | -6.77% | -2.09% | 7.89% | -23.98% | -54.55% | -112.26% | -43.12% | -53.72% |
| Net Income (Continuing) | -9.23M | -12.35M | -7.22M | -11.26M | -13.94M | -13.43M | -11.79M | -11.86M | -11.78M | -10.01M | -9.34M | -9.73M | -11.15M | -11.22M | -8.7M | -8.57M | -10.44M | -10.99M | -9.44M | -6.91M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.14 | -0.18 | -0.11 | -0.17 | -0.21 | -0.28 | -0.25 | -0.25 | -0.26 | -0.22 | -0.21 | -0.22 | -0.25 | -0.23 | -0.18 | -0.19 | -0.24 | -0.25 | -0.23 | -0.17 |
| EPS Growth % | 33.33% | 35.71% | 56% | 32% | 19.23% | -27.27% | -19.05% | -13.64% | -4% | 4.35% | -16.67% | -15.79% | -4.17% | 8% | 21.74% | -11.76% | -41.18% | -78.57% | 17.86% | 10.53% |
| EPS (Basic) | -0.14 | -0.18 | -0.11 | -0.17 | -0.21 | -0.20 | -0.25 | -0.25 | -0.26 | -0.22 | -0.21 | -0.22 | -0.25 | -0.23 | -0.18 | -0.19 | -0.24 | -0.25 | -0.23 | -0.17 |
| Diluted Shares Outstanding | 68.4M | 68.35M | 66.84M | 66.88M | 66.53M | 47.65M | 47.65M | 46.87M | 44.83M | 44.68M | 44.68M | 44.68M | 44.68M | 44.68M | 44.68M | 43.33M | 43.31M | 43.23M | 40.6M | 39.55M |
| Basic Shares Outstanding | 68.4M | 68.35M | 66.84M | 66.88M | 66.53M | 66.52M | 47.65M | 46.87M | 44.83M | 44.68M | 44.68M | 44.68M | 44.68M | 44.68M | 44.68M | 43.33M | 43.31M | 43.23M | 40.59M | 39.55M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |